(Q34260758)

English

Stratification according to HGG-IMMUNO RPA model predicts outcome in a large group of patients with relapsed malignant glioma treated by adjuvant postoperative dendritic cell vaccination

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Stratification according to HGG-IMMUNO RPA model predicts outcome in a large group of patients with relapsed malignant glioma treated by adjuvant postoperative dendritic cell vaccination (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

based on heuristic

inferred from title

4

object named as

Raf Sciot

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

author name string

Steven De Vleeschouwer

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Hilko Ardon

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Frank Van Calenbergh

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Guido Wilms

5

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Johannes van Loon

6

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Jan Goffin

7

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Stefaan Van Gool

8

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

publication date

8 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

61

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

2105-2112

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

The mean does not mean as much anymore: finding sub-groups for tailored therapeutics

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

Use of the RTOG recursive partitioning analysis to validate the benefit of iodine-125 implants in the primary treatment of malignant gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

Radiosurgery in the initial management of malignant gliomas: survival comparison with the RTOG recursive partitioning analysis. Radiation Therapy Oncology Group.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

Prognostic factors for survival in adult patients with recurrent glioma enrolled onto the new approaches to brain tumor therapy CNS consortium phase I and II clinical trials

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

Primary brain tumours in adults.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

Endpoints, patient selection, and biomarkers in the design of clinical trials for cancer vaccines

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

Transient local response and persistent tumor control in a child with recurrent malignant glioma: treatment with combination therapy including dendritic cell therapy. Case report

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

Vaccination of glioma patients with fusions of dendritic and glioma cells and recombinant human interleukin 12.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

Results of a phase I dendritic cell vaccine trial for malignant astrocytoma: potential interaction with adjuvant chemotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

Immunogenicity and antitumor effects of vaccination with peptide vaccine+/-granulocyte-monocyte colony-stimulating factor and/or IFN-alpha2b in advanced metastatic melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

Dendritic cell therapy of high-grade gliomas.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

The WHO classification of tumors of the nervous system

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

“Mini-mental state”

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

Dendritic cell vaccination in patients with malignant gliomas: current status and future directions.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

Survival benefit of Boron neutron capture therapy for recurrent malignant gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

A comparison of treatment results for recurrent malignant gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

Bevacizumab and chemotherapy for recurrent glioblastoma: a single-institution experience

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

Bevacizumab and irinotecan for recurrent oligodendroglial tumors.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

Reoperation for recurrent glioblastoma and anaplastic astrocytoma

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

Re-operations of supratentorial anaplastic astrocytomas.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1271-Z

21 January 2018

Identifiers

10.1007/S00262-012-1271-Z

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34260758&oldid=2196434744"